Comment to text by Leif Thuesen,“PCI-The ugly duckling”
M Dellborg - Scandinavian Cardiovascular Journal, 2007 - Taylor & Francis
Leif Thuesen, an interventional cardiologist, comments my editorial comment on PCI using
another of HC … Dr Thuesen should be congratulated on his thorough reading of HC Andersen. …
another of HC … Dr Thuesen should be congratulated on his thorough reading of HC Andersen. …
Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular …
JC Nielsen, HR Andersen, PEB Thomsen, L Thuesen… - Circulation, 1998 - Am Heart Assoc
… Acceptable comments are posted to the journal website only. Comments are not published
in an issue and are not indexed in PubMed. Comments should be no longer than 500 words …
in an issue and are not indexed in PubMed. Comments should be no longer than 500 words …
Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy
…, P Søgaard, WY Kim, M Bøttcher, L Thuesen… - Circulation, 2001 - Am Heart Assoc
… Acceptable comments are posted to the journal website only. Comments are not published
in an issue and are not indexed in PubMed. Comments should be no longer than 500 words …
in an issue and are not indexed in PubMed. Comments should be no longer than 500 words …
ABSORB cohort a trial: five year clinical and MSCT results of the ABSORB bioresorbable everolimus eluting vascular scaffold
K Nieman, D Dudek, J Ormiston, L Thuesen… - 2011 - Am Heart Assoc
… Acceptable comments are posted to the journal website only. Comments are not published
in an issue and are not indexed in PubMed. Comments should be no longer than 500 words …
in an issue and are not indexed in PubMed. Comments should be no longer than 500 words …
Atrioventricular conduction during long-term follow-up of patients with sick sinus syndrome
HR Andersen, JC Nielsen, PEB Thomsen, L Thuesen… - Circulation, 1998 - Am Heart Assoc
… Acceptable comments are posted to the journal website only. Comments are not published
in an issue and are not indexed in PubMed. Comments should be no longer than 500 words …
in an issue and are not indexed in PubMed. Comments should be no longer than 500 words …
System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention
…, S Trautner, W Vach, SP Johnsen, L Thuesen… - Jama, 2010 - jamanetwork.com
Context Timely reperfusion therapy is recommended for patients with ST-segment elevation
myocardial infarction (STEMI), and door-to-balloon delay has been proposed as a …
myocardial infarction (STEMI), and door-to-balloon delay has been proposed as a …
[HTML][HTML] A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
…, TT Nielsen, K Rasmussen, L Thuesen… - New England journal …, 2003 - Mass Medical Soc
Background For the treatment of myocardial infarction with ST-segment elevation, primary
angioplasty is considered superior to fibrinolysis for patients who are admitted to hospitals …
angioplasty is considered superior to fibrinolysis for patients who are admitted to hospitals …
Stenting of acute left main coronary artery occlusion using balloon anchoring technique after transcatheter aortic valve implantation
…, EH Christiansen, L Thuesen - Journal of Interventional …, 2011 - Wiley Online Library
… Use the link below to share a full-text version of this article with your friends and colleagues.
Learn … The full text of this article hosted at iucr.org is unavailable due to technical difficulties. …
Learn … The full text of this article hosted at iucr.org is unavailable due to technical difficulties. …
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical …
…, J Koolen, B Chevalier, B de Bruyne, L Thuesen… - Journal of the American …, 2011 - jacc.org
Objectives : The aim of this study was to demonstrate that the prevention of early scaffold
area shrinkage of the ABSORB BVS (Rev.1.1, Abbott Vascular, Santa Clara, California) was …
area shrinkage of the ABSORB BVS (Rev.1.1, Abbott Vascular, Santa Clara, California) was …
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
…, SP Johnsen, LO Jensen, HT Sørensen, L Thuesen… - The Lancet, 2010 - thelancet.com
Background In low-risk patients, the zotarolimus-eluting stent has been shown to reduce rates
of restenosis without increasing the risk of stent thrombosis. We compared the efficacy and …
of restenosis without increasing the risk of stent thrombosis. We compared the efficacy and …